Effect of sildenafil versus placebo on prevention and incidence of fetal distress and reduction of emergency cesarean section risk

Phase 3

Recruiting

• Conditions: Emergency cesarean section risk.; Newborn (suspected to be) affected by Cesarean delivery; P03.4

• Registration Number: IRCT20120215009014N435
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

Age of 18 to 50 years
Gestational age of 37 to 42 weeks
Singleton pregnancy
Fetus with cephalic presentation
Candidate for normal delivery

Exclusion Criteria

Fetal anomaly
Chronic diseases such as cardiovascular, renal, liver or hypertension

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eed for emergency cesarean section. Timepoint: Within 24 hours after the intervention. Method of measurement: Based on clinical observation.

Secondary Outcome Measures

Name	Time	Method
Fetal distress. Timepoint: Within two weeks after the intervention. Method of measurement: Based on clinical observation.;Neonatal or maternal mortality. Timepoint: Within two weeks after the intervention. Method of measurement: Based on clinical observation.